R&Dplatform

Contact Us

 

 

  

Address: Beijing's xizhimen south street, xicheng district

 

The British garden 1 floor. Room 824

 

Zip code: 100035

 

Telephone: 010-58562339

 

Fax: 010-58562339

 

Email address: cngjzj@163.com

 

Web site (click on the url link directly left) :

 

http://www.cngjzj.com/

 

Blog (click on the url link directly left) :

http://blog.sina.com.Cn/CNGJZJ

 

To xizhimen south street, xicheng district building to the British garden route

L airport line 1

Take the airport shuttle from the airport, the dongzhimen station transfer to metro line 2 to xizhimen direction and get off at xizhimen station, from C outbound, go straight to the east 100 meters on the right side to xizhimen south street, north to walk to the t-junction namely to the British garden 1 floor downstairs.

L airport line 2

From the capital airport take airport bus to xidan, get off at no.22, take a taxi to xizhimen south street English garden 1 floor.

L bus subway near:

106 bus GuanYuan: 107 road, express way

Bus: xizhimen south road 387, 44 road, inner ring 800, 816 road, inner ring 820, 845 road

Che zhuang: subway line two

Xizhimen subway: metro line 2

Buses and attempts: 107 road, 118 road, 701 road

Buses and north zhuang: 209 road, 375 road, 392 road

 

Your position is: Home >> R&Dplatform >> R&Dplatform

Chinese scientists found that the new method "tumor immunotherapy

2016年03月20日

复制链接 打印 大 中 小

<

 

 

 

Chinese scientists found that the new method "tumor immunotherapy

 

March 19, 2016

Source: xinhua news agency

 

Shanghai, March 18 (xinhua) (reporter Lynn) Shanghai life science college of Chinese academy of sciences institute of biochemistry and cell biology rain gemany team and bo-liang li group, recently found a new way to promote T cell antitumor effect, namely by regulatory T cells key targets change its metabolic state. As a result, the team also found a new drug targets, for the development of new methods of "tumor immunotherapy" laid a foundation. Related work has been published online on the 17th international authoritative journal nature.

It is understood that the appearance of the tumor and the disorders of the body's immune system have a close relationship, the scientific community is generally believed that "tumor immunotherapy" likely from the repair of the body's immune system to provide a cure for cancer, "root", "the ultimate antidote. And T cells are important in the monitoring and kill tumor, clinical often by increasing the activity of T cells to treat tumor.

Rain march and bo-liang li team in the research on the antitumor immune function of T cells found that T cell metabolic pathways of cholesterol esterification enzyme (ACAT1) is a very good control targets, inhibit its activity can greatly improve the antitumor function of killer T cells. Meanwhile, in experiments with mice, the scientists found that small molecule inhibitors of ACAT1 Avasimibe have good antitumor effect. If the inhibitor with the existing clinical tumor immunotherapy drugs used in combination with anti - PD - 1, the effect is better, on the one hand, can improve the effectiveness of the treatment of tumor, on the other hand can also reduce the dosage, toxic and side effects.

Hong-yang wang academicians think Oriental liver and gallbladder surgery hospital, the study opens the "tumor immunotherapy" a whole new field of study, prove that the tumor cell metabolism, immune response plays a key role, found ACAT1 this new drug targets at the same time, reveals the application prospect of ACAT1 small molecule inhibitors, for tumor immunotherapy provides a new way of thinking and new methods.